Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
HSIC vs SNYR: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
HSIC Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 8–2 Matrix Metrics)
HSIC Overall Winner
6-Pillar Tally: HSIC 4 – 2 SNYR
Matrix Metrics: HSIC 8 – 2 SNYR
As of Nov 20, 2026, Henry Schein Inc (HSIC) is the stronger overall head-to-head candidate over Synergy CHC Corp. (SNYR) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). HSIC carries a Unified Composite Score of 50.9/100 (HOLD) at $83.52 (13.9x Forward P/E, 5.8% operating margin), whereas SNYR carries 48.9/100 (HOLD) at $0.09 (0.6x Forward P/E, -10.3% operating margin).
- Technical & Structure Timing Caution: HSIC is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 44.5); meanwhile SNYR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About HSIC vs SNYR
HSIC
Head-to-Head Winner
Henry Schein Inc
$83.52
-1.51% 1D
Market Cap
$9.4B
TTM Revenue
$13.7B
Forward P/E
13.9x
Beta / 30D Vol
0.55β · 40% Vol
Unified Composite Score
50.9
HOLD
Tech 50.0
Fund 53.0
Flow 58.0
Mom 50.0
Weinstein Technical Phase
Distribution · Trim / tighten stop
SNYR
Synergy CHC Corp. Common Stock
$0.09
-67.02% 1D
Market Cap
$4.1M
TTM Revenue
$28M
Forward P/E
0.6x
Beta / 30D Vol
-0.86β · 868% Vol
Unified Composite Score
48.9
HOLD
Tech 55.0
Fund 39.0
Flow 50.0
Mom 60.0
Weinstein Technical Phase
Neutral · Hold
6-Pillar Scorecard Institutional Category Breakdown (HSIC 4 – 2 SNYR)
1. Valuation Multiples
SNYR
Forward P/E
13.9x
0.6x
Trailing P/E
23.2x
0.6x
PEG Ratio
1.67x
N/M
EV / Revenue
1.0x
0.1x
2. Growth & Scale
HSIC
Revenue Growth (YoY)
+4.0%
-32.8%
Earnings Growth (YoY)
+26.2%
-90.6%
TTM Revenue (USD)
$13.7B
$28M
Market Cap
$9.4B
$4.1M
3. Profitability & Quality
HSIC
Gross Margin
31.6%
65.4%
Operating Margin
5.8%
-10.3%
Net Profit Margin
3.1%
-57.0%
Return on Equity (ROE)
9.2%
-361.1%
4. Balance Sheet & Cash Flow
HSIC
Cash Generation (TTM)
$500M
-$3.8M
Cash Flow Margin
3.6%
-13.7%
Net Cash / Leverage
$3.71B Net Debt (1.23x D/E)
-361.1% ROE
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
HSIC
Options Structure Phase
UNCLASSIFIED
UNCLASSIFIED
Current IV / %ile
29.4% (8th %ile)
N/A (N/A)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
NEUTRAL · Distribution
NEUTRAL · Neutral
6. R&D & Supply-Chain Moat
SNYR
OpEx & R&D Intensity
25.8% of Rev ($3.54B)
75.7% of Rev ($21M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Medical Distribution Operator
Medical Distribution Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: HSIC (8) vs SNYR (2)| Institutional Metric | HSIC | SNYR | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $9.4B | $4.1M | HSIC | |
| Trailing P/E Ratio | 23.2x | 0.6x | SNYR | |
| Forward P/E Ratio | 13.9x | 0.6x | SNYR | |
| Revenue Growth (YoY) | +4.0% | -32.8% | HSIC | |
| Operating Margin (TTM) | 5.8% | -10.3% | HSIC | |
| Net Profit Margin | 3.1% | -57.0% | HSIC | |
| Return on Equity (ROE) | 9.2% | -361.1% | HSIC | |
| 52-Week Range Position | 63% ($69–$92) | 1% ($0–$3) | HSIC | |
| Beta / 30D Volatility | 0.55β · 40% Vol | -0.86β · 868% Vol | HSIC | |
| Unified Institutional Score | 50.9 / 100 (HOLD) | 48.9 / 100 (HOLD) | HSIC | |
| Trailing 12M Revenue (USD) | $13.7B | $28M | Scale | |
| Gross Profit Margin (TTM) | 31.6% | 65.4% | Quality | |
| PEG Ratio & EV / Revenue | 1.67x PEG · 1.0x EV/Rev | N/M PEG · 0.1x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | $500M ($3.71B Net Debt (1.23x D/E)) | -$3.8M (-361.1% ROE) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
HSIC +11.58 pp
3M Horizon
HSIC +62.98 pp
6M Horizon
HSIC +109.5 pp
1Y Horizon
HSIC +116.58 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | HSIC Revenue | SNYR Revenue | HSIC Op. Margin | SNYR Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $9.42B | $30M | 6.4% | -14.5% | HSIC |
| FY2019 | $9.99B | $30M | 7.2% | -27.1% | HSIC |
| FY2020 | $10.1B | N/A | 5.3% | N/A | HSIC |
| FY2021 | $12.4B | N/A | 6.9% | N/A | HSIC |
| FY2022 | $12.7B | N/A | 5.9% | N/A | HSIC |
| FY2023 | $12.3B | $40M | 5.0% | 25.3% | SNYR |
| FY2024 | $12.7B | $30M | 4.9% | 16.7% | SNYR |
| FY2025 | $13.2B | $30M | 5.0% | -27.8% | HSIC |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
HSIC
UNCLASSIFIED
Current IV
29.4%
IV Percentile
8th %ile
Put/Call OI Skew
N/A
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
Exact HSIC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
SNYR
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact SNYR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
HSIC Moat Profile
Cyclical / Execution-Driven Positioning
Medical Distribution Operator
OpEx & R&D Reinvestment
25.8% of Rev ($3.54B)
90D Engineering Disclosures
0 Published
SNYR Moat Profile
Cyclical / Execution-Driven Positioning
Medical Distribution Operator
OpEx & R&D Reinvestment
75.7% of Rev ($21M)
90D Engineering Disclosures
0 Published
Investor FAQ HSIC vs SNYR Key Questions & Quantitative Answers
As of Nov 20, 2026, Henry Schein Inc (HSIC) is the stronger overall head-to-head candidate over Synergy CHC Corp. (SNYR) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). HSIC carries a Unified Composite Score of 50.9/100 (HOLD) at $83.52 (13.9x Forward P/E, 5.8% operating margin), whereas SNYR carries 48.9/100 (HOLD) at $0.09 (0.6x Forward P/E, -10.3% operating margin). Technical & Structure Timing Caution: HSIC is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 44.5); meanwhile SNYR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
HSIC leads the Growth & Scale pillar: HSIC posts +4.0% YoY revenue growth and +26.2% YoY earnings growth on $13.7B TTM revenue (31.6% gross margin, 5.8% operating margin), compared with SNYR at -32.8% YoY revenue growth and -90.6% YoY earnings growth on $28M TTM revenue (65.4% gross margin, -10.3% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), HSIC cumulative revenue shifted +39.9% while SNYR shifted +0.0%. In operating R&D and SG&A reinvestment, HSIC deploys 25.8% of Rev ($3.54B) (0 90-day corporate R&D disclosures) versus 75.7% of Rev ($21M) (0 disclosures) for SNYR.
SNYR screens cheaper on headline valuation multiples. HSIC trades at 13.9x Forward P/E, 23.2x Trailing P/E, 1.67x PEG, and 1.0x EV/Revenue (3.6% FCF margin), whereas SNYR trades at 0.6x Forward P/E, 0.6x Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-13.7% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HSIC (9.2% ROE) versus SNYR (-361.1% ROE) capital efficiency.
In options market volatility and institutional positioning, HSIC carries 29.4% implied volatility (8th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.55β · 40% Vol realized risk). By comparison, SNYR carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.86β · 868% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
SNYR vs HSIC · Reverse Pair
HSIC vs XRAY
· Sector Peer
HSIC vs COO
· Sector Peer
HSIC vs UHS
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma
AVGO vs MRVL
· Custom ASIC & Networking